Cosette Pharmaceuticals, Inc.
Bridgewater Township, NJ
- UEI
- HDQFPZ3SBV24
- CAGE
- 8EQ02
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 200 Crossing Blvd #4, Bridgewater Township, NJ 08807, USA
- Website
- cosettepharma.com
- Founded
- 2019
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $122,652 |
| FY2025 | $18,842 |
| FY2024 | $0 |
| FY2023 | $170,640 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Veterans Affairs | $122,652 |
Contract vehicles
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Janssen Pharmaceuticals, Inc. | Hopewell Township, NJ | 325412 Pharmaceutical Preparation Manufacturing |
| Acey RX LLC | Cranbury Township, NJ | 325412 Pharmaceutical Preparation Manufacturing |
| Ferring Pharmaceuticals Inc. | Parsippany-Troy Hills, NJ | 325412 Pharmaceutical Preparation Manufacturing |
| Solco Healthcare US LLC | Franklin Township, NJ | 325412 Pharmaceutical Preparation Manufacturing |
| Centocor Ortho Biotech Inc. | Horsham, PA | 325414 Biological Product (except Diagnostic) Manufacturing |
About the company
Cosette Pharmaceuticals, Inc., a for-profit pharmaceutical manufacturer headquartered in Bridgewater Township, New Jersey, supplies branded and generic pharmaceutical products to the Department of Veterans Affairs as a prime contractor under the GSA Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), competing full-and-open with no set-aside designations across all recent awards.
Cosette's federal footprint consists entirely of pharmaceutical supply delivery orders to VA medical facilities. The vendor specializes in branded specialty pharmaceuticals, with the majority of recent work concentrated on VYLEESI (bremelanotide) 1.75 mg/0.3 ml autoinjectors for the treatment of hypoactive sexual desire disorder. Representative prime awards include a $33,647 delivery order from Veterans Integrated Service Network 20 (VISN 20) in December 2025 for bulk VYLEESI autoinjectors, a $14,557.20 order from VISN 1 in February 2026 for VYLEESI boxes of four units, and a $170,640 small-business-set-aside purchase order from VISN 15 in January 2023 for Clomiphene Citrate Tablets 50 mg to replenish the VA Consolidated Mail Out-Patient Pharmacy at Leavenworth, Kansas.
Customer concentration sits heavily with Veterans Integrated Service Networks. The top five VISN regions account for 80% of awards by count: VISN 20 leads with eight awards totaling $86 thousand in combined potential value, followed by VISN 12 (two awards, $227 thousand), VISN 15 (two awards, $180 thousand), VISN 10 (two awards, $17 thousand), and VISN 19 (two awards, $5 thousand). The potential-value ranking reflects a single large Clomiphene Citrate order at VISN 15 in January 2023; absent that award, VISN 20's recurring VYLEESI orders dominate both volume and dollars. All twenty awards flow through the GSA Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule vehicle, which enables VA medical facilities to place orders against pre-negotiated pharmaceutical pricing; sixteen of the twenty awards carry task-order or delivery-order designations under this schedule.
Activity accelerated from 2022 onward, with one award each in 2020 and 2022, one in 2023, six in 2025, and eleven in 2026 through August. Two awards with ultimate completion dates in the next twenty-four months carry combined potential value of $61 thousand and face recompete exposure. Cosette operates exclusively as a prime contractor with no identified subcontractors; the source carries no sub-award footprint. The vendor registered in the System for Award Management in June 2019 and has consistently supplied specialized pharmaceuticals to the VA across multiple VISN regions, with place of performance at either Bridgewater or South Plainfield, New Jersey.
Quick answers
Is Cosette Pharmaceuticals, Inc. registered in SAM.gov?
Yes. Cosette Pharmaceuticals, Inc.'s SAM.gov registration is active through March 31, 2027.
What is Cosette Pharmaceuticals, Inc.'s CAGE code?
Cosette Pharmaceuticals, Inc.'s CAGE code is 8EQ02, and its Unique Entity ID (UEI) is HDQFPZ3SBV24.
Which contract vehicles does Cosette Pharmaceuticals, Inc. hold?
Cosette Pharmaceuticals, Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.
How much has Cosette Pharmaceuticals, Inc. received in federal contracts?
Federal contracts obligated $18,842 to Cosette Pharmaceuticals, Inc. in fiscal year 2025 and $312,134 in fiscal years 2023 through 2027.
What is Cosette Pharmaceuticals, Inc.'s most recent federal award?
Cosette Pharmaceuticals, Inc.'s most recent federal contract award is Bremelanotide 1.75MG/0.3ML autoinjector vyleesi (36C25026F0668), from Veterans Integrated Service Network 10 (VHA), on August 18, 2026.
On GovTribe
See Cosette Pharmaceuticals, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors